The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...
Techno-Science.net on MSN
When a synthetic tiny fiber self-replicates in the brain
Multiple system atrophy (MSA) is a rare and severe neurodegenerative disease, caused by the massive and rapid accumulation of ...
The magic line that transitions someone from mild cognitive impairment to dementia is when one of their cognitive impairments ...
One million people in the UK have dementia and it already kills more people than cancer or heart disease - usually from ...
Ethan Hawke told "CBS Sunday Morning" that after working with Robin Williams, he realized the actor's "charisma came at a ...
He was principal at Wheaton North High School for 9 years and helped mend frayed relations between Wheaton’s two high schools ...
Patients with MCI, regardless of subtype, have a higher risk of developing hypertension, diabetes, and hyperlipidemia than cognitively normal individuals.
Acadia Pharmaceuticals Inc. is rated a Buy for its steady NUPLAZID/DAYBUE franchises & pipeline-driven upside potential. Read ...
Significant reduction in key neurodegeneration biomarker correlated with treatment response, suggesting neflamapimod may act on underlying disease CervoMed preparing to initiate Phase 3 registrational ...
An international hub for research and information about Alzheimer’s and other forms of dementia will get a new home because ...
The List on MSN
'80s stars who met tragically strange fates
There's little disputing that the '80s were a wild time in pop culture, and the tragically strange fates of some of its stars ...
MedPage Today on MSN
Neflamapimod Shows Promise in Dementia With Lewy Bodies
Neflamapimod is an oral p38 alpha kinase inhibitor that targets dysfunction and degeneration of acetylcholine-producing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback